To examine the effect of co-occurring depressive symptoms and functional disability on mortality in older Mexican-American adults with diabetes mellitus. DESIGN: Longitudinal cohort study. SETTING: Hispanic Established Populations for the Epidemiological Study of the Elderly (HEPESE) survey conducted in the southwestern United States (Texas, Colorado, Arizona, New Mexico, California). PARTICIPANTS: Community-dwelling Mexican Americans with self-reported diabetes mellitus participating in the HEPESE survey (N = 624). MEASUREMENTS: Functional disability was assessed using a modified version of the Katz activity of daily living scale. Depressive symptoms were measured using the Center for Epidemiologic Studies Depression Scale. Mortality was determined by examining death certificates and reports from relatives. Cox proportional hazards regression analyses were used to examine the hazard of mortality as a function of co-occurring depressive symptoms and functional disability. RESULTS: Over a 9.2-year follow-up, 391 participants died. Co-occurring high depressive symptoms and functional disability increased the risk of mortality (hazard ratio (HR) = 3.02, 95% confidence interval (CI) = 2.11-4.34). Risk was greater in men (HR = 8.11, 95% CI = 4.34-16.31) than women (HR = 2.21, 95% CI = 1.42-3.43). CONCLUSION: Co-occurring depressive symptoms and functional disability in older Mexican-American adults with diabetes mellitus increases mortality risk, especially in men. These findings have important implications for research, practice, and public health interventions. J Am Geriatr Soc 64:e154-e159, 2016.
D
iabetes mellitus is one of the leading causes of morbidity and mortality in the United States, with greater incidence and prevalence in elderly adults and minorities. According to the Centers for Disease Control and Prevention, the prevalence of diabetes mellitus is increasing in minority subpopulations, particularly Hispanics, 1 thereby increasing concerns about further exacerbation of racial and social disparities in diabetes mellitus-related morbidity and mortality. Adults diagnosed with diabetes mellitus are at greater risk of mortality than those without. 2 Co-occurring pathological conditions further exacerbate risk of mortality. 3 Co-occurring conditions such as depressive symptoms and functional disability have been shown to be detrimental to health. 4 Mexican Americans are reported to have high rates of diabetes mellitus and are at risk of high depressive symptoms and functional disability as they age. 3 Research indicates that high depressive symptoms and functional disability are independently associated with greater risk of mortality in older Hispanic adults with diabetes mellitus. 3, 5 Studies assessing the effects of depression on diabetes mellitus have reported greater risk in participants with major depression and depressive symptoms, with women having greater risk than men. 6, 7 Research further indicates that adults with diabetes mellitus are at greater risk of functional disability. 8, 9 In one study, older Mexican-American adults with diabetes mellitus reported 74% more disability than those without in activities of daily living (ADLs). 9 Another study found that ADLs were associated with mortality, showing a negative gradient effect on median life expectancy with disability severity. 10 Although research has shown that individuals with diabetes mellitus who have high depressive symptoms or functional disability have poorer health outcomes, poorer quality of life, and greater mortality risk, 3, 11 little is known about how the effects of co-occurring functional disability and depressive symptoms may affect mortality in older adults with diabetes mellitus. Given the burden of diabetes mellitus in the Mexican-American community and the high prevalence of depressive symptoms and functional disability in older adults, the goal was to examine the independent and co-occurring effect of depressive symptoms and functional disability on mortality in Mexican Americans aged 75 and older with self-reported diagnosed diabetes mellitus. A second goal was to assess sex differences in the effects of co-occurring functional disability and high depressive symptoms on mortality in this cohort.
METHODS
This study used data from the Hispanic Established Population for the Epidemiologic Studies of the Elderly (HEP-ESE) cohort study. The HEPESE, which was initiated in 1993-94, is an ongoing community-based study of older Mexican Americans residing in five southwestern states (Texas, California, Arizona, Colorado, New Mexico). At baseline, 3,050 participants aged 65 and older were enrolled in the study, with an additional cohort of 902 participants added at Wave 5 (2004/05), and followed up approximately every 2-3 years for eight waves (2012/13). Interviews were conducted in Spanish or English, depending on the participant's preference. Sampling procedures of the HEPESE were previously described and are available elsewhere. 12 Wave 5 was treated as baseline for the current study.
Inclusion and Exclusion Criteria
The inclusion criteria required participants to have been diagnosed with diabetes mellitus at Wave 5, conducted during 2004-05 when subjects were aged 75 and older. Participants were asked whether a doctor had ever told them that they had diabetes mellitus, sugar in their urine, or high blood glucose. Of 690 who responded affirmatively, 16 were lost to follow-up, leaving 674 eligible participants.
Variables of Interest
All-cause mortality was the outcome of interest. Mortality was determined by examining death certificates (National Death Index) and reports from relatives. Follow-up time was calculated as the difference between the interview date in Wave 5 and most-recent wave participation or date of death until December 31, 2013.
The primary predictor variables of interest were Center for Epidemiologic Studies Depression Scale (CES-D) score and ADL functional disability at baseline (Wave 5). The CES-D is a validated, reliable instrument that has been used extensively to measure depressive symptoms. 13 It consists of 20 questions, with possible scores ranging from 0 to 60. Participants rate the frequency of specific symptoms experienced in the past week on a 4-point Likert scale that ranges from rarely or none of the time (<1 day) to most or all of the time (5-7 days). Using the sum of scores, an ordinal variable was created with two discrete categories: low depressive symptoms (CES-D score 0-15) and high depressive symptoms (CES-D scores ≥16). Functional disability was defined using a modified version of the Katz ADL scale 14 (range 0-7 ADL dependencies). The ADLs included walking across a small room, moving from a bed to a chair, bathing, grooming, dressing, eating, and using the toilet. Participants unable to perform the task or requiring assistance with one or more ADLs were considered to have functional disability. The CES-D has been validated as a measure of depressive symptoms in English-and Spanish-speaking Mexican Americans, 15 and the Katz ADL scale has been widely used in studies of community-dwelling older Mexican Americans. 16, 17 Additional covariates included age (treated as a continuous variable), sex (male, female), education (none, <6th grade, ≥7th grade), marital status (married, not married), visit to a doctor in the previous year (yes, no), diabetes mellitus medication (insulin and oral hypoglycemic, insulin only, oral hypoglycemic only), duration with diabetes mellitus (<15, ≥15 years), diabetes mellitus complications (0, ≥1; eyes, amputations, circulation, kidney), physician-diagnosed hypertension (yes, no), ever had a heart attack (yes, no), ever had a stroke (yes, no), and body mass index (BMI) based on measured height and weight. BMI was treated as an ordinal variable with three discrete categories: underweight or normal weight (<24.9 kg/m . Underweight and normal weight were combined because of the small number of participants with a BMI less than 18.5 kg/m 2 (n = 11).
Missing Data
Of the 690 participants with diabetes mellitus at baseline, 16 were lost to follow-up. Fifty participants (7.4%) had missing data on depressive symptoms. These participants were older and less educated and were more likely to have had diabetes mellitus for longer than 15 years. Additional variables with missing data were diabetes mellitus medications (n = 59, 8.8%), doctor visits (n = 10, 1.5%), hypertension (n = 5), stroke (n = 4), and heart attack (n = 4). Participants were likely to have missing data on more than one variable. BMI data were unavailable for 85 (12.6%) participants, raising concerns about nonresponse bias. To address this, participants with missing BMI observations were included in the analysis by creating a BMI category for missing values to see whether their association with mortality would differ from that of participants for whom BMI data were available. The analytical sample therefore consisted of 624 participants.
Statistical Analysis
Participants were categorized into four groups based on prevalent depressive symptoms and functional status at baseline: no functional disability and low depressive symptoms, functional disability and low depressive symptoms, co-occurring functional disability and high depressive symptoms, and no functional disability and high depressive symptoms. Descriptive analyses of the sample were summarized using means and standard deviations for continuous variables and frequencies and percentages for categorical variables. Comparisons of functional disability and depressive symptoms status were made using analysis of variance tests for continuous variables and chi-square tests for categorical variables. The association between the four baseline depressive symptoms and functional disability groups and mortality was assessed using unadjusted Kaplan-Meier survival curves.
Cox proportional hazards regression analyses were used to examine the hazard of mortality as a function of depressive symptoms and functional disability groups in three models. Analysis was first conducted separately according to depressive symptoms (Model 1) and functional disability (Model 2) to show the independent effect of each on mortality. Further analyses were performed according to the four groups of depressive symptoms and functional status (Model 3) to assess their co-occurring effect on mortality. All three models controlled for the aforementioned covariates. To examine how the co-occurrence of depressive symptoms and functional disability influenced mortality differently in men and women with diabetes mellitus, sex-stratified analysis was conducted when an interaction between sex and predictor variables of interest was significant. All tests of statistical significance were two-sided, with significance set at P < .05. Analyses were performed using Stata version 12.0 (Stata Corp, College Station, TX) and SAS version 9.3 (SAS Institute, Inc., Cary, NC).
RESULTS
Average age at baseline (2004-05) was 81.0, and 63.6% of participants were female. Two hundred forty-eight participants (42.20%) reported at least one functional disability, and 132 (21.19%) had high depressive symptoms. Of the 624 study participants, 51.4% (n = 321) had no functional disability and low depressive symptoms, 27.4% (n = 171) had functional disability and low depressive symptoms, 11.4% (n = 71) had co-occurring functional disability and high depressive symptoms, and approximately 10% (n = 61) had no functional disability and high depressive symptoms (Table 1) . Approximately 9% of men and almost 13% of women reported co-occurring high depressive symptoms and functional disability. Participants who were not married (12.4%), were less educated (18.1%), had a history of stroke (23.5%) or heart attack (14.3%), were taking insulin and an oral hypoglycemic (21.4%), and reported disease duration of 15 years or longer (12.9%) more commonly reported co-occurring high depressive symptoms and functional disability. Approximately 40% of participants with missing BMI had co-occurring high depressive symptoms and functional disability.
The study follow-up period was 9.2 years. Overall mean follow-up was 5.2 years, with 391 of 624 participants dying. Unadjusted Kaplan-Meier curves (Figure 1 ) indicated that participants with no functional disability and low depressive symptoms survived the longest and that those with no functional disability and high depressive symptoms had intermediate survival. Differences in survival between the groups were statistically significant (logrank test, P < .001). Participants with both conditions fared worst. Similar trends were noted according to sex (Figure 1) . Table 2 shows the fully adjusted HR for the association between mortality and depressive symptoms (Model 1), functional disability (Model 2), and co-occurring functional disability and depressive symptoms (Model 3). In Model 1, high depressive symtoms were associated with greater risk of mortality than low depressive symptoms (HR = 1.92, 95% CI = 1.48-2.48). In Model 2, participants reporting functional disability had a greater risk of mortality (HR = 1.74, 95% CI = 1.38-2.19). A significant interaction between sex and functional disability prompted a sex-stratified analysis that indicated greater risk of mortality for older men (HR = 2.27, 95% CI = 1.55-3.31) than older women (HR = 1.47, 95% CI = 1.09-1.97).
Model 3 shows the hazard ratios for the association between co-occurring functional disability and depressive symptoms and mortality. The risk of mortality was three times as great in participants with co-occurring high depressive symptoms and functional disability (HR = 3.02, 95% CI = 2.11-4.34). The covariates age, disease duration, diabetes mellitus complications, doctor visits in the past year, and history of stroke were significantly associated with mortality. In addition, participants with cooccurring functional disability and depressive symptoms whose BMI information was missing had a significant 73% greater risk of mortality.
Attenuation of risk for female participants (HR = 0.58, 95% CI = 0.45-0.75) and a significant interaction term prompted sex-stratified analysis, which indicated that women were twice as likely (HR = 2.21, 95% CI = 1.42-3.43) and that men were eight times as likely (HR = 8.11, 95% CI = 4.34-16.31) to have died during the study interval. Visiting a doctor in the past year and diabetes mellitus complications significantly increased the risk of mortality in men only, and history of stroke significantly increased the risk of mortality in women only (HR = 1.76, 95% CI = 1.21-2.57). Obesity had a significant protective effect in men but not women.
DISCUSSION
Similar to previous studies, this study found that high depressive symptoms and functional disability were independently associated with mortality in older adults with diabetes mellitus. 10, 18 The current study contributes to the literature by demonstrating that, in elderly Mexican Americans with diabetes mellitus, co-occurring high depressive symptoms and functional disability compound the risk of mortality, particularly in men.
Previous research has shown that women are more vulnerable than men to incident diabetes mellitus, high depressive symptoms, functional disability, and co-occurring high depressive symptoms and functional disability. [19] [20] [21] Despite being more vulnerable to these conditions, women in the current study had a lower risk of mortality than men. A similar survival disadvantage in elderly men has been previously reported. 10 In the current study, men who had visited a doctor in the past year had greater risk of mortality. Men are reportedly less likely to use health care such doctor's visits and preventive care visits, 22 whereas individuals with poor or deteriorating health have a greater propensity to use health care. 23 A paradoxic association between BMI and mortality in individuals with chronic conditions has been reported in the literature. 24, 25 The obesity paradox was evident in men but not women in the current study. There was a lower albeit nonsignificant inverse association with mortality in overweight and obese women, whereas obese men had a significantly lower risk of mortality.
Missing data on BMI raised concerns about nonresponse bias in the data because obesity is independently associated with diabetes mellitus, functional disability, and Participants with complete information to identify the co-occurrence of functional disability and depressive symptoms were included in this analysis (N = 624).
With the exception of education, heart attack, and hypertension, all participant characteristics were statistically significant across the four groups of prevalent depressive symptoms and functional status at baseline. The effect of sex was not statistically significant. SD = standard deviation.
high depressive symptoms. 1, 26 Inclusion of participants with missing BMI data allowed for the assessment of differential outcomes between those with missing BMI data and those with BMI data. The highest rates of co-occurring functional disability and high depressive symptoms were observed in participants with missing data, who also had a significantly greater risk of mortality. Women with missing BMI data had greater risk of mortality, particularly if they reported high depressive symptoms. These findings suggest that exclusion of participants with missing data on BMI may lead to systematic underestimation. 27 The current study findings should be viewed in light of several limitations. The diabetes mellitus variable was based on self-report, which may affect results because of recall bias, misinterpretation, or simplification. 28 In addition, the use of the CES-D to measure depressive symptoms in lieu of formal depression diagnosis through structured clinical interviews warrants caution in the interpretation of the results. Latent cross-cultural factors may influence CES-D scores, which may affect their diagnostic accuracy. 29, 30 In using standard screening tools such as the CES-D, older Mexican-American adults reportedly corroborated depressive symptoms more than other cultural groups with similar levels of depressive symptomatology, 29 resulting in response bias and overdiagnosis. Despite these shortcomings, use of a large, representative, longitudinal cohort of community-dwelling older Mexican Americans from the southwestern United States strengthen these findings. Studies assessing how co-occurring conditions such as high depressive symptoms and functional disability affect mortality in adults with diabetes mellitus are lacking particularly in this population, and the current study was able to partially address this gap in the literature. Further investigation into effects of co-occurring depression and functional status in individuals with diabetes mellitus is warranted. Because diabetes mellitus prevalence, functional disability, and high depressive symptoms continue to be major public health burdens in the Mexican-American community, the findings of this study and additional related studies will become increasingly important and hold important implications for research, practice, and public health interventions. In Cox regression analysis, there was no violation of the proportionality assumption assessed by the significance of a term of the predictor associated with the logarithm of survival time. The reference categories in each model were low depressive symptoms (Model 1), no functional disability (Model 2) and (no functional disability, low depressive symptoms (Model 3). For all modeling analyses, a body mass index (BMI) category for missing values was included. The results for missing category are not shown. Adjusted for age education, sex, marital status, BMI, diabetes mellitus complications, duration of diabetes mellitus (years), diabetes mellitus medication, hypertension, heart attack, stroke, visited doctor in past year. 
